SecSonar.com

Nuwellis, Inc. (NUWE)

Nuwellis, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Nuwellis, Inc. (NUWE) is a Medical - Devices company based in US with a market capitalization of $686.1K. Revenue declined 5.4% year-over-year and free cash flow was negative at -$10.9M. This page tracks NUWE's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 38 employees · IPO Feb 16, 2012

Valuation

Valuation & price

$0.99 · as of May 17, 2026 · -99.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.26

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$552$277$3.12Jul 25Dec 25Jul 26Jul 7, 25$248.85Jul 9, 25$258.30Jul 11, 25$240.80Jul 15, 25$241.50Jul 17, 25$551.60Jul 21, 25$527.45Jul 23, 25$484.05Jul 25, 25$424.20Jul 29, 25$368.20Jul 31, 25$336.00Aug 4, 25$231.35Aug 6, 25$182.00Aug 11, 25$173.60Aug 13, 25$192.50Aug 15, 25$193.90Aug 19, 25$208.60Aug 21, 25$185.15Aug 25, 25$184.80Aug 27, 25$180.25Aug 29, 25$178.50Sep 3, 25$172.55Sep 5, 25$170.80Sep 9, 25$151.90Sep 11, 25$147.35Sep 16, 25$144.55Sep 18, 25$132.30Sep 22, 25$127.40Sep 24, 25$126.00Sep 26, 25$121.80Sep 30, 25$117.25Oct 2, 25$116.20Oct 6, 25$123.55Oct 8, 25$132.30Oct 10, 25$122.50Oct 14, 25$121.45Oct 16, 25$119.70Oct 21, 25$112.00Oct 23, 25$106.05Oct 27, 25$113.05Oct 29, 25$106.75Oct 31, 25$100.10Nov 4, 25$94.15Nov 6, 25$97.30Nov 10, 25$94.85Nov 12, 25$93.45Nov 14, 25$94.50Nov 18, 25$82.60Nov 20, 25$73.15Nov 25, 25$77.00Nov 28, 25$85.40Dec 2, 25$79.10Dec 4, 25$92.05Dec 8, 25$94.85Dec 10, 25$99.40Dec 12, 25$79.80Dec 16, 25$77.35Dec 18, 25$75.60Dec 22, 25$75.25Dec 24, 25$72.10Dec 29, 25$63.70Jan 2, 26$63.35Jan 6, 26$71.40Jan 8, 26$68.95Jan 12, 26$70.70Jan 14, 26$66.50Jan 16, 26$66.50Jan 21, 26$65.10Jan 23, 26$77.70Jan 27, 26$134.05Jan 29, 26$146.65Feb 2, 26$134.75Feb 4, 26$105.70Feb 9, 26$92.05Feb 11, 26$77.35Feb 13, 26$68.95Feb 18, 26$65.10Feb 20, 26$64.75Feb 24, 26$56.35Feb 26, 26$56.00Mar 2, 26$52.15Mar 4, 26$54.60Mar 6, 26$50.05Mar 10, 26$45.50Mar 12, 26$44.80Mar 17, 26$37.80Mar 19, 26$35.35Mar 23, 26$38.85Mar 25, 26$40.25Mar 27, 26$36.75Mar 31, 26$36.75Apr 2, 26$38.15Apr 7, 26$39.55Apr 9, 26$37.80Apr 13, 26$42.00Apr 15, 26$43.05Apr 17, 26$41.30Apr 22, 26$40.25Apr 24, 26$41.30Apr 28, 26$38.85Apr 30, 26$39.55May 4, 26$39.20May 6, 26$38.15May 8, 26$38.15May 12, 26$36.05May 14, 26$35.70May 18, 26$34.25May 20, 26$34.63May 22, 26$36.75May 28, 26$29.72Jun 1, 26$24.50Jun 3, 26$16.99Jun 5, 26$5.85Jun 9, 26$5.08Jun 11, 26$4.90Jun 15, 26$4.77Jun 17, 26$4.83Jun 22, 26$4.55Jun 24, 26$3.12Jun 26, 26$3.30Jul 2, 26$3.15
$3.0552-week range$558.25
Loading valuation history…

Fundamentals

Key fundamentals

$686.1K

Market cap

-5.4%

Revenue growth (YoY)

62.0%

Gross margin

-$10.9M

Free cash flow (USD)

-$757K

Net debt

Net cash position

420.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.3MFY 2017$3.6MFY 2018$5.0MFY 2019$5.5MFY 2020$7.4MFY 2021$7.9MFY 2022$8.5MFY 2023$8.9MFY 2024$8.7MFY 2025$8.3M
$1.3M$8.3M

Free cash flow by year

2016 → 2025

FY 2016$-16.4MFY 2017$-12.2MFY 2018$-14.8MFY 2019$-16.9MFY 2020$-16.9MFY 2021$-18.1MFY 2022$-15.3MFY 2023$-18.2MFY 2024$-9.7MFY 2025$-10.9M
-$16.4M-$10.9M

Gross margin by year

2021 → 2025

FY 202156.7%FY 202255.7%FY 202356.2%FY 202466.7%FY 202562.0%
56.7%62.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 15, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventReverse Stock SplitJun 23, 2026Filing
  • 8-K eventCEO ChangeJun 18, 2026Filing
  • 8-K eventPublic Offering ClosedJun 10, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • 8-K eventAnnual Meeting ResultsApr 29, 2026Filing
  • 8-K eventSettlement AgreementApr 24, 2026Filing
  • 8-K eventDirector Resignation ResponseApr 1, 2026Filing

Questions

Frequently asked questions

What is Nuwellis, Inc.'s market cap?

Nuwellis, Inc. (NUWE) has a market capitalization of $686.1K.

What is NUWE's P/E ratio?

A meaningful P/E ratio is not available for NUWE — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is NUWE's price-to-book (P/B) ratio?

NUWE trades at 0.26 times book value per share.

Are insiders buying NUWE stock?

SEC Form 4 filings show no open-market insider buys at Nuwellis, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

TIVC

Tivic Health Systems, Inc.

$849.3K

VTAK

Catheter Precision, Inc.

$940K

AEMD

Aethlon Medical, Inc.

$1.7M

XAIR

Beyond Air, Inc.

$2.4M

IVF

INVO Fertility, Inc.

$2.4M

PAVM

PAVmed Inc.

$3.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.